Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Lance C. Balk currently holds 59,883 shares of TomoTherapy Inc (TOMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Lance C. Balk has been a net seller of TOMO stock. They have purchased $1.4M and sold $30.0M worth of shares.
Lance C. Balk's most recent insider trade was on Aug 3, 2026, when they sold 10,000 shares at $0.00 per share.
Lance C. Balk serves as Executive at TomoTherapy Inc (TOMO). They have executed 161 insider transactions totaling $31.4M over their tenure at the company.
Lance C. Balk holds the position of Executive at TomoTherapy Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Lance C. Balk has shown a selling trading pattern, with $1.4M in total purchases and $30.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Lance C. Balk was on Feb 27, 2018, when they sold $5.3M worth of SIX shares. This transaction involved 80,720 shares at $65.49 per share.
Lance C. Balk currently owns 59,883 shares of TomoTherapy Inc (TOMO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Lance C. Balk's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Lance C. Balk has 161 Form 4 filings on record as an insider at TomoTherapy Inc.
Set alerts for Lance C. Balk and 40,000+ other insiders.